COMBINED-MODALITY THERAPY FOR ESOPHAGEAL CANCER - PHASE-I TRIAL OF ESCALATING DOSES OF PACLITAXEL IN COMBINATION WITH CISPLATIN, 5-FLUOROURACIL, AND HIGH-DOSE RADIATION BEFORE ESOPHAGECTOMY
Lm. Weiner et al., COMBINED-MODALITY THERAPY FOR ESOPHAGEAL CANCER - PHASE-I TRIAL OF ESCALATING DOSES OF PACLITAXEL IN COMBINATION WITH CISPLATIN, 5-FLUOROURACIL, AND HIGH-DOSE RADIATION BEFORE ESOPHAGECTOMY, Seminars in oncology, 24(6), 1997, pp. 93-95